Collegium Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	150.1	70.57	238.95	173.69	186.43	174.12
Short-Term Investments	135.77	92.2	71.6	-	-	-
Cash & Short-Term Investments	285.86	162.76	310.55	173.69	186.43	174.12
Cash Growth	138.30%	-47.59%	78.80%	-6.83%	7.07%	2.41%
Accounts Receivable	233.95	228.54	179.53	183.12	105.84	83.32
Receivables	233.95	228.54	179.53	183.12	105.84	83.32
Inventory	38.05	35.56	32.33	46.5	17.39	15.61
Prepaid Expenses	36.16	21.94	11.05	11.49	5.85	4.39
Restricted Cash	19.85	25	-	-	-	-
Other Current Assets	-	8.45	4.15	5.2	0.03	0.45
Total Current Assets	613.87	482.26	537.6	419.99	315.54	277.89
Property, Plant & Equipment	16.68	20.15	22.01	26.38	27.14	27.38
Goodwill	145.93	162.33	133.86	133.7	-	-
Other Intangible Assets	724.98	891.4	421.71	567.47	268.72	335.9
Long-Term Deferred Tax Assets	102.48	98.03	26.26	23.95	78.04	-
Other Long-Term Assets	3.39	9.42	1.87	2.65	2.63	2.67
Total Assets	1,607	1,664	1,143	1,174	692.08	643.84
Accounts Payable	7.65	3.93	8.69	3.49	4.19	10.02
Accrued Expenses	217.93	251.55	185.26	193.07	167.75	157.43
Current Portion of Long-Term Debt	64.58	64.58	183.33	162.5	48.35	47.5
Current Portion of Leases	1.37	1.27	0.99	1.11	0.81	0.73
Current Income Taxes Payable	0.8	8.53	2.14	-	0.62	-
Current Unearned Revenue	0.67	-	-	-	-	-
Other Current Liabilities	159.94	179.64	77.51	73.55	57.84	23.78
Total Current Liabilities	452.93	509.51	457.92	433.73	279.57	239.45
Long-Term Debt	865.81	908.52	483.84	538.45	201.63	209.59
Long-Term Leases	4.5	5.54	6.12	7.11	7.95	8.77
Long-Term Unearned Revenue	9.28	10	-	-	-	-
Other Long-Term Liabilities	-	1.18	-	-	-	-
Total Liabilities	1,333	1,435	947.88	979.29	489.15	457.81
Common Stock	0.04	0.04	0.04	0.04	0.04	0.04
Additional Paid-In Capital	615.08	590.25	565.95	538.07	502.1	519.14
Retained Earnings	-118.09	-164	-233.19	-281.34	-256.34	-333.15
Treasury Stock	-222.51	-197.51	-137.38	-61.92	-42.86	-
Comprehensive Income & Other	0.29	0.06	0.01	-	-	-
Total Common Equity	274.81	228.84	195.43	194.84	202.93	186.03
Shareholders' Equity	274.81	228.84	195.43	194.84	202.93	186.03
Total Liabilities & Equity	1,607	1,664	1,143	1,174	692.08	643.84
Total Debt	936.27	979.91	674.28	709.18	258.75	266.58
Net Cash (Debt)	-650.41	-817.15	-363.74	-535.49	-72.32	-92.47
Net Cash Per Share	-16.40	-20.21	-8.70	-15.83	-1.76	-2.63
Filing Date Shares Outstanding	31.61	31.49	31.96	34.07	33.38	34.76
Total Common Shares Outstanding	31.6	31.44	31.87	33.85	33.66	34.61
Working Capital	160.94	-27.25	79.69	-13.74	35.98	38.44
Book Value Per Share	8.70	7.28	6.13	5.76	6.03	5.37
Tangible Book Value	-596.1	-824.89	-360.13	-506.32	-65.8	-149.87
Tangible Book Value Per Share	-18.86	-26.24	-11.30	-14.96	-1.95	-4.33
Machinery	-	25.83	24.6	24.97	18.46	17.92
Construction In Progress	-	0.8	-	-	5.18	3.58
Leasehold Improvements	-	1.23	1.06	0.87	0.54	0.54

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q